Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Chrystyn

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
BMC Health Services Research|July 14, 2016
The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countriesA Lewis, S Torvinen, P N R Dekhuijzen, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Improved bioavailability from a spironolactone beta-cyclodextrin complexN T Yusuff, P York, H Chrystyn, et al.
Respiratory Medicine|July 23, 2017
Budesonide + formoterol delivered via Spiromax<sup>®</sup> for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler<sup>®</sup>A Lewis, S Torvinen, P N R Dekhuijzen, et al.
The European Respiratory Journal|February 12, 2011
What the pulmonary specialist should know about the new inhalation therapiesB L Laube, H M Janssens, F H C de Jongh, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
BMC Health Services Research|July 14, 2016
The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countriesA Lewis, S Torvinen, P N R Dekhuijzen, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Improved bioavailability from a spironolactone beta-cyclodextrin complexN T Yusuff, P York, H Chrystyn, et al.
Respiratory Medicine|July 23, 2017
Budesonide + formoterol delivered via Spiromax<sup>®</sup> for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler<sup>®</sup>A Lewis, S Torvinen, P N R Dekhuijzen, et al.
The European Respiratory Journal|February 12, 2011
What the pulmonary specialist should know about the new inhalation therapiesB L Laube, H M Janssens, F H C de Jongh, et al.
Pageof 8